Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,632,278
  • Shares Outstanding, K 101,773
  • Annual Sales, $ 168,800 K
  • Annual Income, $ 67,970 K
  • 60-Month Beta 1.82
  • Price/Sales 21.61
  • Price/Cash Flow 46.24
  • Price/Book 7.38
  • Price/Earnings ttm 398.22
  • Earnings Per Share ttm 0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.07
  • Number of Estimates 7
  • High Estimate 0.65
  • Low Estimate -0.35
  • Prior Year 0.21
  • Growth Rate Est. (year over year) -133.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.50 +13.30%
on 05/01/20
40.01 -10.80%
on 04/28/20
-1.25 (-3.38%)
since 04/22/20
3-Month
19.51 +82.93%
on 03/18/20
40.02 -10.82%
on 04/20/20
-2.80 (-7.27%)
since 02/21/20
52-Week
19.51 +82.93%
on 03/18/20
73.72 -51.59%
on 11/29/19
+13.90 (+63.79%)
since 05/22/19

Most Recent Stories

More News
Arrowhead Pharma Rises 2.42% on Heavy Volume: Watch For Potential Pullback

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $35.03 to a high of $37.26. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high...

ARWR : 35.69 (-0.42%)
Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal second quarter ended March 31, 2020. The company is hosting a conference call at 4:30 p.m. EDT to discuss...

ARWR : 35.69 (-0.42%)
Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the retirement of Bruce Given, M.D., Arrowhead's chief operating officer and head of R&D, which was previously planned and disclosed, after...

ARWR : 35.69 (-0.42%)
Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 35.69 (-0.42%)
After Yesterday's Decline of 1.40%, Arrowhead Pharma Offers Investors Better Value

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $34.86 to a high of $36.38. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

ARWR : 35.69 (-0.42%)
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Second Quarter Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on May 7, 2020, at 4:30 p.m. EDT to discuss its financial results for the fiscal second quarter...

ARWR : 35.69 (-0.42%)
Arrowhead Pharma Rises 8.70% on Heavy Volume: Watch For Potential Pullback

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $35.72 to a high of $40.00. Yesterday, the shares gained 8.7%, which took the trading range above the 3-day high...

ARWR : 35.69 (-0.42%)
Arrowhead Pharma Set to Possibly Pullback After Yesterday's Rally of 2.31%

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $33.68 to a high of $35.74. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high...

ARWR : 35.69 (-0.42%)
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has filed an application for clearance to begin a Phase 1/2a clinical trial of ARO-ENaC, the company's investigational RNA interference...

ARWR : 35.69 (-0.42%)
First Week of May 15th Options Trading For Arrowhead Pharmaceuticals (ARWR)

Investors in Arrowhead Pharmaceuticals Inc saw new options begin trading this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARWR options...

ARWR : 35.69 (-0.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ARWR with:

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 36.50
1st Resistance Point 36.09
Last Price 35.69
1st Support Level 35.04
2nd Support Level 34.40

See More

52-Week High 73.72
Fibonacci 61.8% 53.01
Fibonacci 50% 46.62
Fibonacci 38.2% 40.22
Last Price 35.69
52-Week Low 19.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar